Foto del docente

Francesco Massari

Ricercatore a tempo determinato tipo b) (senior)

Dipartimento di Scienze Mediche e Chirurgiche

Settore scientifico disciplinare: MED/06 ONCOLOGIA MEDICA

Pubblicazioni

Conci, Nicole; Tassinari, Elisa; Tateo, Valentina; Rosellini, Matteo; Marchetti, Andrea; Ricci, Costantino; Chessa, Francesco; Santoni, Matteo; Grande, Enrique; Mollica, Veronica; Massari, Francesco, How Do Molecular Classifications Affect the Neoadjuvant Treatment of Muscle-Invasive Urothelial Carcinoma?, «MOLECULAR DIAGNOSIS & THERAPY», 2023, 1, pp. 1 - 15 [articolo]

Rizzo, Alessandro; Mollica, Veronica; Tateo, Valentina; Tassinari, Elisa; Marchetti, Andrea; Rosellini, Matteo; De Luca, Raffaele; Santoni, Matteo; Massari, Francesco, Hypertransaminasemia in cancer patients receiving immunotherapy and immune-based combinations: the MOUSEION-05 study, «CANCER IMMUNOLOGY, IMMUNOTHERAPY», 2023, 1, pp. 1 - 14 [articolo]

Rizzo, Alessandro; Nuvola, Giacomo; Palmiotti, Gennaro; Ahcene-Djaballah, Selma; Mollica, Veronica; Rosellini, Matteo; Marchetti, Andrea; Nigro, Maria Concetta; Tassinari, Elisa; Macrini, Sveva; Massari, Francesco, Hypertransaminasemia in metastatic renal cell carcinoma patients receiving immune-based combinations: a meta-analysis, «IMMUNOTHERAPY», 2023, 1, pp. 1 - 10 [articolo]

Thais Maloberti; Antonio De Leo; Sara Coluccelli; Viviana Sanza; Elisa Gruppioni; Annalisa Altimari; Stefano Zagnoni; Francesca Giunchi; Francesco Vasuri; Michelangelo Fiorentino; Veronica Mollica; Simona Ferrari; Sara Miccoli; Michela Visani; Daniela Turchetti; Francesco Massari; Giovanni Tallini; Dario de Biase, Multi-Gene Next-Generation Sequencing Panel for Analysis of BRCA1/BRCA2 and Homologous Recombination Repair Genes Alterations Metastatic Castration-Resistant Prostate Cancer, «INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES», 2023, 24, Article number: 8940, pp. 8940 - 8954 [articolo]Open Access

Costantino Ricci, Maria Sirolli, Francesca Ambrosi, Tania Franceschini, Francesca Giunchi, Federico Mineo Bianchi, Riccardo Schiavina, francesco Massari, Veronica Mollica, Michelangelo Fiorentino, Thais Maloberti, Giovanni Tallini, Dario de Biase, Mutations of NOTCH Genes as an Alternative Mechanism to Activate mTOR pathway in Low-grade Oncocytic Tumor (LOT) of the Kidney, in: 2023 USCAP Annual Meeting Abstracts, 2023, pp. 247 - 247 (atti di: 2023 USCAP Annual Meeting, New Orleans Ernest N. Morial Convention Center, 11-16 Marzo 2023) [atti di convegno-abstract]

Antonarakis, Emmanuel S; Park, Se Hoon; Goh, Jeffrey C; Shin, Sang Joon; Lee, Jae Lyun; Mehra, Niven; McDermott, Ray; Sala-Gonzalez, Núria; Fong, Peter C; Greil, Richard; Retz, Margitta; Sade, Juan Pablo; Yanez, Patricio; Huang, Yi-Hsiu; Begbie, Stephen D; Gafanov, Rustem Airatovich; De Santis, Maria; Rosenbaum, Eli; Kolinsky, Michael P; Rey, Felipe; Chiu, Kun-Yuan; Roubaud, Guilhem; Kramer, Gero; Sumitomo, Makoto; Massari, Francesco; Suzuki, Hiroyoshi; Qiu, Ping; Zhang, Jinchun; Kim, Jeri; Poehlein, Christian H; Yu, Evan Y, Pembrolizumab Plus Olaparib for Patients With Previously Treated and Biomarker-Unselected Metastatic Castration-Resistant Prostate Cancer: The Randomized, Open-Label, Phase III KEYLYNK-010 Trial, «JOURNAL OF CLINICAL ONCOLOGY», 2023, 1, pp. 1 - 15 [articolo]

Marchetti, Andrea; Tassinari, Elisa; Rosellini, Matteo; Rizzo, Alessandro; Massari, Francesco; Mollica, Veronica, Prostate cancer and novel pharmacological treatment options - what's new for 2022?, «EXPERT REVIEW OF CLINICAL PHARMACOLOGY», 2023, 1, pp. 1 - 14 [articolo]

Rosellini, Matteo; Tassinari, Elisa; Marchetti, Andrea; Mollica, Veronica; Massari, Francesco, Re: Atezolizumab Plus Cabozantinib Versus Cabozantinib Monotherapy for Patients with Renal Cell Carcinoma After Progression with Previous Immune Checkpoint Inhibitor Treatment (CONTACT-03): A Multicentre, Randomised, Open-label, Phase 3 Trial, «EUROPEAN UROLOGY», 2023, 1, pp. 1 - 2 [articolo]

Tateo, Valentina; Mollica, Veronica; Rizzo, Alessandro; Santoni, Matteo; Massari, Francesco, Re: WHO Classification of Tumours, 5th Edition, Volume 8: Urinary and Male Genital Tumours, «EUROPEAN UROLOGY», 2023, 1, pp. 1 - 2 [articolo]

Santoni, Matteo; Myint, Zin W; Büttner, Thomas; Takeshita, Hideki; Okada, Yohei; Lam, Elaine T; Gilbert, Danielle; Küronya, Zsófia; Tural, Deniz; Pichler, Renate; Grande, Enrique; Crabb, Simon J; Kemp, Robert; Massari, Francesco; Scagliarini, Sarah; Iacovelli, Roberto; Vau, Nuno; Basso, Umberto; Maruzzo, Marco; Molina-Cerrillo, Javier; Galli, Luca; Bamias, Aristotelis; De Giorgi, Ugo; Zucali, Paolo Andrea; Rizzo, Mimma; Seront, Emmanuel; Popovic, Lazar; Caffo, Orazio; Buti, Sebastiano; Kanesvaran, Ravindran; Kopecky, Jindrich; Kucharz, Jakub; Zeppellini, Annalisa; Fiala, Ondřej; Landmesser, Johannes; Ansari, Jawaher; Giannatempo, Patrizia; Rizzo, Alessandro; Zabalza, Ignacio Ortego; Monteiro, Fernando Sabino M; Battelli, Nicola; Calabrò, Fabio; Porta, Camillo, Real-world effectiveness of pembrolizumab as first-line therapy for cisplatin-ineligible patients with advanced urothelial carcinoma: the ARON-2 study, «CANCER IMMUNOLOGY, IMMUNOTHERAPY», 2023, 72, pp. 2961 - 2970 [articolo]

Raschi E.; Comito F.; Massari F.; Gelsomino F., Relatlimab and nivolumab in untreated advanced melanoma: insight into RELATIVITY, «IMMUNOTHERAPY», 2023, 15, pp. 85 - 91 [articolo]

Matteo Santoni; Javier Molina-Cerrillo; Giorgio Santoni; Elaine T. Lam; Francesco Massari; Veronica Mollica; Giulia Mazzaschi; Bernardo L. Rapoport; Enrique Grande; Sebastiano Buti, Role of Clock Genes and Circadian Rhythm in Renal Cell Carcinoma: Recent Evidence and Therapeutic Consequences, «CANCERS», 2023, 15, Article number: 408, pp. 1 - 10 [articolo]Open Access

Monteiro, Fernando Sabino Marques; Fiala, Ondřej; Massari, Francesco; Myint, Zin W; Kopecky, Jindrich; Kucharz, Jakub; Büttner, Thomas; Grande, Enrique; Bourlon, Maria Teresa; Molina-Cerrillo, Javier; Pichler, Renate; Buchler, Tomas; Seront, Emmanuel; Ansari, Jawaher; Bamias, Aristotelis; Bhuva, Dipen; Vau, Nuno; Porta, Camillo; Fay, Andre Poisl; Santoni, Matteo, Systemic Immune-Inflammation Index in Patients Treated With First-Line Immune Combinations for Metastatic Renal Cell Carcinoma: Insights From the ARON-1 Study, «CLINICAL GENITOURINARY CANCER», 2023, 1, pp. 1 - 13 [articolo]

Melotti, Sofia; Ambrosi, Francesca; Franceschini, Tania; Giunchi, Francesca; Filippo, Giorgia Di; Franchini, Eugenia; Massari, Francesco; Mollica, Veronica; Tateo, Valentina; Bianchi, Federico Mineo; Colecchia, Maurizio; Acosta, Andres Martin; Lobo, João; Fiorentino, Michelangelo; Ricci, Costantino, TAMs PD-L1(+) in the reprogramming of germ cell tumors of the testis, «PATHOLOGY RESEARCH AND PRACTICE», 2023, 247, pp. 154540 - 154546 [articolo]Open Access

Mollica, Veronica; Tassinari, Elisa; Santoni, Matteo; Marchese, Paola Valeria; Giunchi, Francesca; Maloberti, Thais; Tateo, Valentina; Ricci, Costantino; Rosellini, Matteo; Marchetti, Andrea; Fiorentino, Michelangelo; Biase, Dario De; Massari, Francesco, TERT promoter mutations and the outcome of patients with advanced urothelial carcinoma treated by platinum-based chemotherapy or pembrolizumab, «PATHOLOGY RESEARCH AND PRACTICE», 2023, 253, pp. 155008 - 155013 [articolo]

Ultimi avvisi

Al momento non sono presenti avvisi.